Profile
BCAX VRTX ALNY REGN ARGX SGEN
Company Name Bicara Therapeutics Inc. Common Stock Vertex Pharmaceuticals Incorporated Alnylam Pharmaceuticals, Inc. Regeneron Pharmaceuticals, Inc. argenx SE Seagen Inc.
Sector Healthcare Healthcare Healthcare Healthcare Healthcare Healthcare
Industry Biotechnology Biotechnology Biotechnology Biotechnology Biotechnology Biotechnology
Market Cap $613.83M $101.65B $61.42B $57.97B $46.27B $43.15B
Employees 0.06K 6.10K 2.23K 15.16K 1.60K 3.26K
CEO Claire Mazumdar Clemon Reshma Kewalramani FASN, Yvonne L. Greenstreet Leonard S. Schleifer Timothy Van Hauwermeiren EMBA, David R. Epstein
Ratings
BCAX VRTX ALNY REGN ARGX SGEN
Quant Rating Score 3 4 1 4 4 3
Quant Rating Neutral Buy Strong Sell Buy Buy Neutral
Trading
BCAX VRTX ALNY REGN ARGX SGEN
Last Close $10.97 $387.15 $451.725 $585.5 $734.35 $228.74
High 52 $26.38 $516.74 $482.13 $1150.19 $768 $228.74
Low 52 $8.71 $366.54 $224.58 $482.92 $519.76 $228.74
Price vs. 52 Week High -58.42 % -25.08 % -6.31 % -49.1 % -4.38 % 0 %
Price vs. 52 Week Low 25.95 % 5.62 % 101.14 % 21.24 % 41.29 % 0 %
Total Return
BCAX VRTX ALNY REGN ARGX SGEN
1 Month Return -4.36 % -0.7 % -1.13 % 2.04 % 11.04 % 0 %
3 Month Return 16.33 % -13.66 % 44.64 % 14 % 36.52 % 0 %
6 Month Return -11.82 % -24.42 % 84.91 % -11.98 % 20.15 % 0 %
9 Month Return -33.15 % -13.49 % 89.86 % -18.07 % 17.65 % 0 %
YTD Return -37.03 % -3.86 % 91.97 % -17.8 % 19.41 % 0 %
1 Year Return -57 % -18.35 % 65.38 % -48.59 % 38.8 % 0 %
3 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
5 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
Dividends
BCAX VRTX ALNY REGN ARGX SGEN
Dividend Yield Percentage (TTM) - - - 0.47 % - -
Dividend Paid and Capex Coverage Ration (TTM) -2103.25 % 11.09 % -0.43 % 4.37 % -44.32 % -5.87 %
Dividend Per Share (TTM) - - - 2.64 % - -
Payout Ratio (TTM) - - - 4.18 % - -
Growth
BCAX VRTX ALNY REGN ARGX SGEN
Asset Growth 117.96 % -0.87 %
Gross Profit Growth -194.74 % 10.25 %
Revenue Growth - 11.66 %
Revenue 3 Year - 45.6 %
Revenue 5 Year - 163.93 %
Revenue 10 Year - 1632.15 %
EBIT Growth -30.45 % -93.69 %
Net Income Growth -30.8 % -114.8 %
Net Income 3 Yeari Growth Per Share -70.87 % -122.89 %
Net Income 5 Yeari Growth Per Share -70.87 % -145.38 %
Net Income 10 Yeari Growth Per Share -70.87 % 33.84 %
Operating Income Growth -106.55 % -106.08 %
Operating Cash Flow Growth (CFG) -63.83 % -113.93 %
Operating 3 Year CFG -121.64 % -118.65 %
Operating 5 Year CFG -121.64 % -131.3 %
Operating 10 Year CFG -121.64 % 12.43 %
EPS Growth -25 % -114.8 %
EPS Diluted Growth -25 % -114.97 %
Book Value Per Share 414.45 % -6.59 %
Share Holder 3 Year Equity Growth Per Share 573.47 % 62.6 %
Share Holder 5 Year Equity Growth Per Share 573.47 % 168.85 %
Share Holder 10 Year Equity Growth Per Share 573.47 % 1292.6 %
Dividend Per Share Growth - -
Dividend 3 Year Growth Per Share - -
Dividend 5 Year Growth Per Share - -
Dividend 10 Year Growth Per Share - -
Debt Growth 12.33 % 116.42 %
Free Cash Flow Growth -61.9 % -124.1 %
Updated On 31 Dec 2024 31 Dec 2024
Profitability
BCAX VRTX ALNY REGN ARGX SGEN
Gross Profit Margin TTM - 86.11 % 83.64 % 81.98 % 65.32 % 79.1 %
Return on Assets TTM -22.64 % 15.13 % -6.99 % 11.67 % 15.06 % -16.61 %
Return on Equity TTM -21.67 % 22.14 % -274.21 % 15.11 % 18.96 % -20.8 %
Return on Capital Employed TTM -27.75 % 19.72 % -5.52 % 11.45 % 5.04 % -21.46 %
Net Income Per EBT TTM 100.3 % 83.16 % 84.06 % 91.46 % 237.3 % 101.33 %
EBT Per Ebit TTM 84.55 % 111.48 % 210.66 % 123.23 % 147.38 % 98.26 %
EBIT Per Revenue TTM - 34.36 % -7.32 % 27.83 % 13.47 % -31.24 %
Cash Flow To Debt Ratio TTM -4510.99 % 251.83 % -1.2 % 175.35 % -175.92 % -1043.73 %
Receivables Turnover TTM - 6.03 4.34 2.53 1.91 3.91
Payables Turnover TTM 0.02 0.43 3.93 3.54 0.88 1.97
Inventory Turnover TTM - 1.06 5.62 0.8 2.21 0.96
Fixed Asset Turnover TTM - 431.08 % 355.68 % 293.64 % 5009.77 % 665.41 %
Asset Turnover TTM - 47.51 % 53.92 % 37.19 % 31.97 % 53.41 %
Operating Cash Flow Per Share TTM -1.85 14.98 -0.12 45.13 -1.07 -2.46
Free Cash Flow Per Share TTM -1.85 13.63 -0.4 36.58 -1.09 -2.88
Cash Per Share TTM 800.54 % 3036 % 2203.63 % 7107.14 % 5536.58 % 939.52 %
Operating Cash Flow Sales Ratio TTM - 33.68 % -0.63 % 33.37 % -3.31 % -23.12 %
Free Cash Flow Operating Cash Flow Ratio TTM 100.05 % 90.99 % 335.21 % 81.05 % 102.26 % 117.04 %
Cash Flow Coverage Ratios TTM -4510.99 % 251.83 % -1.2 % 175.35 % -175.92 % -1043.73 %
Price To Free Cash Flows Ratio TTM -6.08 29.05 -1179.18 15.08 -596.18 -81.26
Price To Operating Cash Flows Ratio TTM -6.08 26.46 -3910.39 12.33 -706.75 -93.1
Price Cash Flow Ratio TTM -6.08 26.46 -3910.39 12.33 -706.75 -93.1
Income Statement (TTM)
BCAX VRTX ALNY REGN ARGX SGEN
Revenue $0B $11.02B $2.25B $14.2B $2.19B $1.96B
Gross Profit $-0B $9.49B $1.92B $11.75B $1.96B $1.55B
Gross Profit Ratio 0% 86.11% 85.62% 82.74% 89.62% 79.1%
EBITDA $-0.07B $0.49B $-0.18B $5.32B $0.11B $-0.62B
Net Income $-0.07B $-0.54B $-0.28B $4.41B $0.83B $-0.61B
EPS Diluted -1.25 -2.08 -2.16 38.34 12.78 -3.3
Balance Sheet (MRQ)
BCAX VRTX ALNY REGN ARGX SGEN
Long Term Debt $0B $1.66B $1.25B $2.7B $0.03B $0.04B
Total Liabilities $0.02B $6.12B $4.17B $8.41B $0.7B $0.87B
Total Equity $0.49B $16.41B $0.07B $29.35B $5.5B $2.8B
Total Investments $0B $6.65B $1.73B $15.42B $1.93B $1.42B
Total Debt $0B $1.75B $1.3B $2.7B $0.04B $0.04B
Total Assets $0.51B $22.53B $4.24B $37.76B $6.2B $3.67B
Cash Flow Statement (TTM)
BCAX VRTX ALNY REGN ARGX SGEN
Net Income $-0.07B $-0.54B $-0.28B $4.41B $0.83B $-0.61B
Inventory $0B $-0.52B $0.01B $-0.62B $-0.1B $-0.23B
Dividends Paid $0B $0B $0B $0B $0B $0B
Operating Cash Flow $-0.07B $-0.49B $-0.01B $4.42B $-0.08B $-0.45B
Capital Expenditure $-0B $-0.3B $-0.03B $-0.76B $-0.07B $-0.08B
Related Stocks
Ticker Name Price
AADI Aadi Bioscience, Inc. 2.05
AAPG 39.62
AARD Aardvark Therapeutics, Inc. Common Stock 11.29
ABCL AbCellera Biologics Inc. 4.71
ABCM Abcam plc 23.99
ABEO Abeona Therapeutics Inc. 5.635
ABIO ARCA biopharma, Inc. 28.8
ABOS Acumen Pharmaceuticals, Inc. 1.33
ABPWW 0.046281
ABSI Absci Corporation 2.69
ABUS Arbutus Biopharma Corporation 4.415
ABVC ABVC BioPharma, Inc. 2.723
ABVX Abivax SA American Depositary Shares 83.25
ACAD ACADIA Pharmaceuticals Inc. 24.76
ACER Acer Therapeutics Inc. 0.6601
ACET Adicet Bio, Inc. 0.8101
ACGN Aceragen, Inc. 0.3849
ACHL Achilles Therapeutics plc 1.48
ACHV Achieve Life Sciences, Inc. 2.855
ACIU AC Immune SA 2.57
ETFs With Exposure to BCAX
Ticker ETF Name Weight Percentage Price
IWM iShares Russell 2000 ETF 0.01433 244.85
VTI Vanguard Total Stock Market Index Fund 0.00083 327.17
SCHB Schwab U.S. Broad Market ETF 0.00032283 25.635
ITOT iShares Core S&P Total U.S. Stock Market ETF 0.00113 144.84
SCHA Schwab U.S. Small-Cap ETF 0.0053956 28.32
IWN iShares Russell 2000 Value ETF 0.02821 178.95
IWV iShares Russell 3000 ETF 0.00063 376.77
IWO iShares Russell 2000 Growth ETF 0.00184 323.71
VHT Vanguard Health Care Index Fund 0.00392 256.72
VXF Vanguard Extended Market Index Fund 0.00288 213
HDG ProShares Hedge Replication ETF 0.00195964 51.3853
BBC Virtus LifeSci Biotech Clinical Trials ETF 0.73 25.255
UWM ProShares Ultra Russell2000 0.0112944 47.75
VTHR Vanguard Russell 3000 Index Fund 0.00039 293.43
ONEQ Fidelity Nasdaq Composite Index ETF 0 88.545
URTY ProShares UltraPro Russell2000 0.00811569 55.34
VTWV Vanguard Russell 2000 Value Index Fund 0.02801 158.6
ISCB iShares Morningstar Small-Cap ETF 0.00622 64.355
OMFS Invesco Russell 2000 Dynamic Multifactor ETF 0.005 44.78
SBIO ALPS Medical Breakthroughs ETF 0.36 37.12
VTWG Vanguard Russell 2000 Growth Index Fund 0.00167 236.835
VTWO Vanguard Russell 2000 Index Fund 0.01445 99.29
XSU.TO iShares U.S. Small Cap Index ETF (CAD-Hedged) 0.01 46.76
VITNX Vanguard Institutional Total Stock Market Index Fund Institutional Shares 0.0008 110.6
VITPX Vanguard Institutional Total Stock Market Index Fund Institutional Plus Shares 0 110.58
VBAIX Vanguard Balanced Index Fund Institutional Shares 0.00058 52.41
VBIAX Vanguard Balanced Index Fund Admiral Shares 0.00058 52.4
VBINX Vanguard Balanced Index Fund Investor Shares 0 52.4
AVUS Avantis U.S. Equity ETF 0 108.74
VTSAX Vanguard Total Stock Market Index Fund 0 158.29
R2US.L SPDR Russell 2000 US Small Cap UCITS ETF 0.015031 70.9
VIEIX Vanguard Extended Market Index Fund Institutional Shares 0.00289 158.73
VITSX Vanguard Total Stock Market Index Fund 0 158.32
XRS2.F Xtrackers Russell 2000 UCITS ETF 0.0166331 318.35
SC0K.DE Invesco Russell 2000 UCITS ETF 0.0147 105.68
VEXAX Vanguard Extended Market Index Fd Admiral Shs 0.00289 158.74
RTYS.L Invesco Russell 2000 UCITS ETF 0.0147 124.31
XRSG.L Xtrackers (IE) Public Limited Company - Xtrackers Russell 2000 UCITS ETF 0.0166331 26590
BBSC JPMorgan BetaBuilders U.S. Small Cap Equity ETF 0.02 75.325
XRSU.L Xtrackers (IE) Public Limited Company - Xtrackers Russell 2000 UCITS ETF 0.0166331 360.445
ZPRR.DE SPDR Russell 2000 US Small Cap UCITS ETF 0.015031 60.29
R2SC.L SPDR Russell 2000 US Small Cap UCITS ETF 0.015031 52.42
XRS2.DE Xtrackers Russell 2000 UCITS ETF 0.0166331 306.35
VHCIX Vanguard HealthCare Index Fund Admiral Shs 0.0022 127.71
JKJ iShares Morningstar Small-Cap ETF 0.00622 231.193
TMSL T. Rowe Price Exchange-Traded Funds, Inc. - T. Rowe Price Small-Mid Cap ETF 0.0335133 35.47
VTS.AX Vanguard US Total Market Shares Index ETF 0.00079 493.31
CANC Tema Oncology ETF 0.32 27.7
VEMPX Vanguard Extended Market Index InstlPlus 0.00289 391.73
FESM 0.04 36.99
VSMPX Vanguard Total Stock Mkt Idx Instl Pls 0.00079 296.99
RSSL Global X Funds 0.01 96.495
RFLR Innovator ETFs Trust 0.02 27.905
Unlock